AwarenessPress Release Children’s Tumor Foundation Announces “Make NF Visible” Campaign for NF Awareness Month
Collaborations & PartnershipsPress ReleaseScience & Research Children’s Tumor Foundation and DELopen Form Collaboration to Increase Access to Promising Compounds for Rare Genetic Disorder
Collaborations & PartnershipsNF1Press ReleaseScience & Research FDA Accepts Submission for Selumetinib as Treatment for Neurofibromatosis and Grants Priority Review
Press ReleaseScience & ResearchSpecial EventsWays to Give Children’s Tumor Foundation Hosts National Gala in New York City
Collaborations & PartnershipsNF1Press ReleaseScience & Research SpringWorks Therapeutics Announces FDA Fast Track Designation for PD-0325901 for NF1 Patients
Collaborations & PartnershipsNF2-SWNPress ReleaseScience & Research Children’s Tumor Foundation Provides Funding to NF2 Therapeutics, Inc. to Develop a First-in-Class Gene Therapy for NF2-related schwannomatosis
NF2-SWNPress ReleaseScience & Research Children’s Tumor Foundation Launches NF2 Accelerator Initiative to Combat Rare Genetic Disorder
